A growing single-manager hedge fund based in New York City with over $1bn AUM is looking to bring on a Long/Short Equity Biotech research analyst. In this role you will work closely with the CIO to identify and analyze investment opportunities in the health care sector. The ideal candidate will have a PhD or MD and have several years of buy-side research experience with a deeply fundamental approach to investing. A medical background is not required but it is preferred.
- Strong academic track record, technical or life science degree is preferred
- At least 3 years of buyside biotech analyst experience preferred
- Strong financial modeling skills and a passion for investing, learning, solving complex research questions
Please apply if you meet the qualifications!